Google Search
A well-documented Business Plan aids in business funding and it is proven to help businesses grow by 30% faster.
Test Your Business ideas- We clear your doubts on Business concept and validate it properly. Often Businesses fail when the Business Plan is weak.
Market Research & High Industry Demand- We will analyse the Market Potential for optimal Industry Growth.
- Overview
- Stats
- Introduction
- Information
- Contact Us
- Project At A Glance
- Profitability And Net Cash Accruals
- Cost Of Project
- Asssessement Of Working Capital Requirements
- Profitability Ratios, Dscr, Debt Equity
- Break Even Analysis
- Means Of Finance
- Projected Balance Sheet
- Repayment Of Term Loan
- Debt Service Coverage Ratio
- Depreciation Chart
- Projected Pay-Back Period
- Projected Irr
- Company Summary
- Reasons For Buying The Report
- Our Approach
- Table Of Content
- Financial Plan
- Information/ Disclaimer
Manufacturing of Ciprofloxacin Hydrochloride (CIPRO) - Active Pharma Ingredient
Manufacturing of Ciprofloxacin Hydrochloride (CIPRO) - Active Pharma Ingredient. Investment Opportunity for Startups and Entrepreneurs. Ciprofloxacin is an antibiotic agent in the fluoroquinolone class used to treat bacterial infections such as urinary tract infections and pneumonia. Ciprofloxacin is FDA approved for the treatment of urinary tract infections, sexually transmitted infections (gonorrhea and cancroid), skin, bone and joint infections, prostatitis, typhoid fever, gastrointestinal infections, lower respiratory tract infections, anthrax, plague, and salmonellosis. Related Projects: - Active Pharmaceutical Ingredient (API) Products, Bulk API Manufacturing Uses and Applications Ciprofloxacin only treats bacterial infections; it does not treat viral infections such as the common cold. For certain uses including acute sinusitis, lower respiratory tract infections and uncomplicated gonorrhea, ciprofloxacin is not considered a first-line agent. This antibiotic treats only bacterial infections. It will not work for virus infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. Mycoplasma contamination is a major problem in cell culture in biomedical and biopharmaceutical research, with rates near 15-30%. While there is no method for visual confirmation of mycoplasma, contamination has serious effects on key characteristics and functions of cells, thus compromising any research done. Cipro (ciprofloxacin hydrochloride) is the standard antibiotic for rapid and efficient decontamination. Related Books: - Pharmaceutical, Drugs, Proteins Technology Handbooks CIPRO is indicated in adult patients for treatment of complicated intra-abdominal infections (used in combination with metronidazole) caused by Escherichia coli, Pseudomonas aeruginosa, Proteus mirabilis, Klebsiella pneumoniae, or Bacteroides fragilis. Ciprofloxacin (Cetraxal, Ciloxan, and Cipro) is an inexpensive drug used to treat certain bacterial infections. It is more popular than comparable drugs. Application Urogenital Infections Respiratory Tract Infections Gastrointestinal Infections Typhoid Bone and Joint Infections Skin and Soft Tissue Infections Sepsis and Other Systemic Infections Related Videos: - Pharmaceutical, Drugs, Fine Chemicals, Bulk Drug Intermediates, Pharmaceutical Drugs, Pharma Drug Ingredients Intermediates, Pharmaceutical Bulk Drugs Government Initiatives • Some of the initiatives taken by the Government to promote the pharmaceutical sector in India are as follows: • India plans to set up a nearly Rs 1 lakh crore (US$ 1.3 billion) fund to provide boost to companies to manufacture pharmaceutical ingredients domestically by 2023. • In November 2019, the Cabinet approved extension/renewal of extant Pharmaceuticals Purchase Policy (PPP) with the same terms and conditions while adding one additional product namely, Alcoholic Hand Disinfectant (AHD) to the existing list of 103 medicines till the final closure/strategic disinvestment of Pharma CPSUs. • Under Budget 2020-21, Rs 65,012 crore (US$ 9.30 billion) has been allocated to the Ministry of Health and Family Welfare is. The Government has allocated Rs 34,115 crore (US$ 4.88 billion) towards the National Health Mission under which rural and urban people will get benefited. • Rs 6,400 crore (US$ 915.72 million) has been allocated to health insurance scheme Ayushman Bharat – Pradhan Mantri Jan Arogya Yojana (AB-PMJAY). • As per Economic Survey 2019-20, Government expenditure (as a percentage of GDP) increased to 1.6 per cent in FY20 from 1.2 per cent in FY15 on health. Related Projects: - Pharmaceutical, Drugs, Fine Chemicals, Bulk Drug Intermediates • The National Health Protection Scheme is the largest Government funded healthcare programme in the world, which is expected to benefit 100 million poor families in the country by providing a cover of up to Rs 5 lakh (US$ 7,723.2) per family per year for secondary and tertiary care hospitalisation. The programme was announced in Union Budget 2018-19. • The Government of India is planning to set up an electronic platform to regulate online pharmacies under a new policy to stop any misuse due to easy availability. • Government of India unveiled 'Pharma Vision 2020' to make India a global leader in end-to-end drug manufacture. Approval time for new facilities has been reduced to boost investment. • India has imposed a provisional anti-dumping duty on imports of Ciprofloxacin Hydrochloride from China on the grounds that it was hurting domestic industry, following an investigation of the Directorate General of Trade Remedies (DGTR). • The department of revenue issued a notification to the effect on September 2, imposing a duty ranging between $0.94 and $3.29 per kg coming from China. • Ciprofloxacin Hydrochloride is used to treat different types of bacterial infections and certain types of diarrhea. The DGTR had initiated the investigation in January this year. Related Videos: - Industrial, Medical and Specialty Gases Manufacturing Project Ideas Market Outlook The India ciprofloxacin market is segmented based on composition, source, and form, route of administration, distribution channel, application, end user, company and region. Based on route of administration, the market can be categorized into oral, ophthalmic, optic, and intravenous and others. The intravenous segment is expected to witness significant growth through FY2026. This can be ascribed to the use of this route of administration for the drugs which are not absorbed after consumption through oral route. Additionally, large quantities of drug can be administered using this route of drug administration with 100% bioavailability. The Global Ciprofloxacin Market is growing at a faster pace with substantial growth rates over the last few years and is estimated that the market will grow significantly in the forecasted period i.e. 2020 to 2027. Related Project:- Ciprofloxacin Hydrochloride Indian pharmaceutical sector is expected to grow to US$ 100 billion, while medical device market is expected to grow US$ 25 billion by 2025. Pharmaceuticals export from India stood at US$ 20.70 billion in FY20. Pharmaceutical export include bulk drugs, intermediates, drug formulations, biological, Ayush and herbal products and surgical. The remaining of the active pharmaceutical ingredient of ciprofloxacin is being dispersed in another combination product and specifically utilize in the urinary tract antibiotic only. Thereby anticipated to lure the new market players in the ciprofloxacin market. The higher incidence of skin and immunological disorder is anticipated to offer a steady revenue generation opportunity in the ciprofloxacin market. Increase awareness about safe drug utilization, however increase in adverse drug reaction awareness and stringent government impositions have narrowed the growth path for global Ciprofloxacin market in North America. Furthermore in East Asia region considerably higher market growth rate is expected due to higher utilization of ciprofloxacin in renal infection in the region. Thereby anticipated to increase the revenue generation in the Ciprofloxacin market. Related Projects: - Chemicals (Organic, Inorganic, Industrial) Projects The bulk drugs segment continues to be the highest revenue generating segment for the Indian pharma industry. It accounts for production worth Rs 120 bn and contributes about 36% of the total pharma exports. India produces 400 bulk drugs through its 1,300 licensed bulk drug units that cater to most of the domestic bulk drug requirements. Related Projects: - Active Pharma Ingredients(API) Key Players:- ? Aarti Drugs Ltd. ? Aurobindo Pharma Ltd. ? Cipla Ltd. ? Indoco Remedies Ltd. ? Kores (India) Ltd. ? Mylan Pharmaceuticals Pvt. Ltd. ? Neuland Laboratories Ltd. ? S S Organics Ltd ? Smruthi Organics Ltd. ? Sreepathi Pharmaceuticals Ltd. ? Sterling Basic Organics Ltd. ? Sun Pharma Laboratories Ltd. ? Sun Pharma Medisales Pvt. Ltd. ? Wockhardt Ltd. Tags:- #CiprofloxacinHydrochloride #Ciprofloxacin #CiprofloxacinBusinessPlan #activepharmaceuticalingrediants #activepharmaingredient #Pharmaceutical #pharmaindustry #APIManufacturing #APIProduction #APImarket #APIBusiness #APIbusinessplan #startupAPIbusiness #CIPRO #startyourbusiness #investmentopportunity #covidbusiness #DetailedProjectReport #businessconsultant #BusinessPlan #feasibilityReport #NPCS #bussinessplanshub #Startupbusiness4you #StartupBusinessPlan #startupinvestment #startup #ChemicalIndustry
Plant capacity | Plant & machinery | Working capital | Cost of Project | T.C.I | Return | Break even |
---|---|---|---|---|---|---|
- | - | - | - | 1% | 0% |
Introduction
We can provide you detailed project reports on the following topics. Please select the projects of your interests.
Each detailed project reports cover all the aspects of business, from analysing the market, confirming availability of various necessities such as plant & machinery, raw materials to forecasting the financial requirements. The scope of the report includes assessing market potential, negotiating with collaborators, investment decision making, corporate diversification planning etc. in a very planned manner by formulating detailed manufacturing techniques and forecasting financial aspects by estimating the cost of raw material, formulating the cash flow statement, projecting the balance sheet etc.
We also offer self-contained Pre-Investment and Pre-Feasibility Studies, Market Surveys and Studies, Preparation of Techno-Economic Feasibility Reports, Identification and Selection of Plant and Machinery, Manufacturing Process and or Equipment required, General Guidance, Technical and Commercial Counseling for setting up new industrial projects on the following topics.
Many of the engineers, project consultant & industrial consultancy firms in India and worldwide use our project reports as one of the input in doing their analysis.
- One Lac / Lakh / Lakhs is equivalent to one hundred thousand (100,000)
- One Crore is equivalent to ten million (10,000,000)
- T.C.I is Total Capital Investment
- We can modify the project capacity and project cost as per your requirement.
- We can also prepare project report on any subject as per your requirement.
- Caution: The project's cost, capacity and return are subject to change without any notice. Future projects may have different values of project cost, capacity or return.
COST OF PROJECT | MEANS OF FINANCE | ||||||
---|---|---|---|---|---|---|---|
Particulars | Existing | Proposed | Total | Particulars | Existing | Proposed | Total |
Land & Site Development Exp. | ********** | ********** | ********** | Capital | ********** | ********** | ********** |
Buildings | ********** | ********** | ********** | Share Premium | ********** | ********** | ********** |
Plant & Machineries | ********** | ********** | ********** | Other Type Share Capital | ********** | ********** | ********** |
Motor Vehicles | ********** | ********** | ********** | Reserves & Surplus | ********** | ********** | ********** |
Office Automation Equipments | ********** | ********** | ********** | Cash Subsidy | ********** | ********** | ********** |
Technical Knowhow Fees & Exp. | ********** | ********** | ********** | Internal Cash Accruals | ********** | ********** | ********** |
Franchise & Other Deposits | ********** | ********** | ********** | Long/Medium Term Borrowings | ********** | ********** | ********** |
Preliminary & Pre-operative Exp | ********** | ********** | ********** | Debentures / Bonds | ********** | ********** | ********** |
Provision for Contingencies | ********** | ********** | ********** | Unsecured Loans/Deposits | ********** | ********** | ********** |
Margin Money - Working Capital | ********** | ********** | ********** | ********** | ********** | ********** | ********** |
Total | ********** | ********** | ********** | Total | ********** | ********** | ********** |
PARTICULARS | OPERATING YEARS | ||||
---|---|---|---|---|---|
1-2 | 2-3 | 3-4 | 4-5 | 5-6 | |
********** | ********** | ********** | ********** | ********** | |
Revenue/Income/Realisation | ********** | ********** | ********** | ********** | ********** |
Gross Sales Realisation | ********** | ********** | ********** | ********** | ********** |
Less : Excise Duties/Levies | ********** | ********** | ********** | ********** | ********** |
Net Sales Realisation | ********** | ********** | ********** | ********** | ********** |
Total Revenue/Income/Realisation | ********** | ********** | ********** | ********** | ********** |
********** | ********** | ********** | ********** | ********** | |
Expenses/Cost of Products/Services/Items | ********** | ********** | ********** | ********** | ********** |
Raw Material Cost | ********** | ********** | ********** | ********** | ********** |
Indigenous | ********** | ********** | ********** | ********** | ********** |
Total Nett Consumption | ********** | ********** | ********** | ********** | ********** |
Lab & ETP Chemical Cost | ********** | ********** | ********** | ********** | ********** |
Packing Material Cost | ********** | ********** | ********** | ********** | ********** |
Sub Total of Net Consumption | ********** | ********** | ********** | ********** | ********** |
Miscellaneous Cost | ********** | ********** | ********** | ********** | ********** |
Employees Expenses | ********** | ********** | ********** | ********** | ********** |
Fuel Expenses | ********** | ********** | ********** | ********** | ********** |
Power/Electricity Expenses | ********** | ********** | ********** | ********** | ********** |
Depreciation | ********** | ********** | ********** | ********** | ********** |
Royalty & Other Charges | ********** | ********** | ********** | ********** | ********** |
Repairs & Maintenance Exp. | ********** | ********** | ********** | ********** | ********** |
Other Mfg. Expenses | ********** | ********** | ********** | ********** | ********** |
Cost of Output of Goods Sold | ********** | ********** | ********** | ********** | ********** |
********** | ********** | ********** | ********** | ********** | |
Gross Profit | ********** | ********** | ********** | ********** | ********** |
Administration Expenses | ********** | ********** | ********** | ********** | ********** |
Technical Knowhow Fees & Exp. | ********** | ********** | ********** | ********** | ********** |
Financial Charges | ********** | ********** | ********** | ********** | ********** |
Long/Medium Term Borrowing | ********** | ********** | ********** | ********** | ********** |
On Wkg. Capital Borrowings | ********** | ********** | ********** | ********** | ********** |
Total Financial Charges | ********** | ********** | ********** | ********** | ********** |
Selling Expenses | ********** | ********** | ********** | ********** | ********** |
Total Cost of Sales | ********** | ********** | ********** | ********** | ********** |
********** | ********** | ********** | ********** | ********** | |
Net Profit Before Taxes | ********** | ********** | ********** | ********** | ********** |
Tax on Profit | ********** | ********** | ********** | ********** | ********** |
Net Profit After Taxes | ********** | ********** | ********** | ********** | ********** |
Depreciation Added Back | ********** | ********** | ********** | ********** | ********** |
Technical Knowhow Fees & Exp. | ********** | ********** | ********** | ********** | ********** |
Net Cash Accruals | ********** | ********** | ********** | ********** | ********** |
PARTICULARS | EXISTING | PROPOSED | TOTAL |
---|---|---|---|
COST OF PROJECT | |||
Land & Site Development Exp. | |||
Land Area Required | ********** | ********** | ********** |
Land Development Cost, Boundary Wall, Gate & Road etc. | ********** | ********** | ********** |
********** | ********** | ********** | |
Buildings | ********** | ********** | ********** |
Factory Building - | ********** | ********** | ********** |
Office Buildings | ********** | ********** | ********** |
********** | ********** | ********** | |
Plant & Machineries | ********** | ********** | ********** |
Indigenous Machineries | ********** | ********** | ********** |
Erection & Installation | ********** | ********** | ********** |
Laboratory Equipments | ********** | ********** | ********** |
Miscellaneous Equipments like pumps, valves, pipeline & fittings | ********** | ********** | ********** |
Imported Machineries | ********** | ********** | ********** |
Technical know how | ********** | ********** | ********** |
********** | ********** | ********** | |
Office Vehicles | ********** | ********** | ********** |
Office Automation Equipments (Telephone/ Fax/ Computer) | ********** | ********** | ********** |
Office Equipment, Furniture plus Other Equipment & Accessories | ********** | ********** | ********** |
Other Misc. Assets | ********** | ********** | ********** |
********** | ********** | ********** | |
Pre-operative & Preliminary Expenses | ********** | ********** | ********** |
Provision for Contingencies | ********** | ********** | ********** |
********** | ********** | ********** | |
Total Capital Cost of Project | ********** | ********** | ********** |
Margin Money for Working Capital | ********** | ********** | ********** |
Total Cost of Project | ********** | ********** | ********** |
PARTICULARS | STK.PRD. | STK.PRD. | OPERATING YEARS | |||||
---|---|---|---|---|---|---|---|---|
1st Year | 2nd Yr &+ | 1-2 | 2-3 | 3-4 | 4-5 | 5-6 | ||
Capacity | Months | Months | % | ********** | ********** | ********** | ********** | ********** |
CURRENT ASSETS | ********** | ********** | ********** | ********** | ********** | |||
Stocks on Hand | ********** | ********** | ********** | ********** | ********** | |||
Raw Material Cost | ********** | ********** | ********** | ********** | ********** | |||
Indigenous | ********** | ********** | M | ********** | ********** | ********** | ********** | ********** |
Lab & ETP Chemical | ********** | ********** | M | ********** | ********** | ********** | ********** | ********** |
Packing Material | ********** | ********** | M | ********** | ********** | ********** | ********** | ********** |
Consumable Store | ********** | ********** | M | ********** | ********** | ********** | ********** | ********** |
Work-in-Process | ********** | ********** | D | ********** | ********** | ********** | ********** | ********** |
Finished Goods | ********** | ********** | M | ********** | ********** | ********** | ********** | ********** |
Current Expenses | ********** | ********** | M | ********** | ********** | ********** | ********** | ********** |
Receivables | ********** | ********** | M | ********** | ********** | ********** | ********** | ********** |
********** | ********** | ********** | ********** | ********** | ********** | ********** | ||
Total | ********** | ********** | ********** | ********** | ********** | |||
Cash/Bank Balances | ********** | ********** | ********** | ********** | ********** | |||
Gross Wkg. Capital | ********** | ********** | ********** | ********** | ********** |
PARTICULARS | OPERATING YEARS | |||||
---|---|---|---|---|---|---|
1-2 | 2-3 | 3-4 | 4-5 | 5-6 | ||
Profit Percentages to Net Sales | ||||||
Gross Profit | ********** | ********** | ********** | ********** | ********** | |
% Of G.P. to Net Sales | ********** | ********** | ********** | ********** | ********** | |
Net Profit Before Taxes | ********** | ********** | ********** | ********** | ********** | |
% of N.P.B.T. To Net Sales | ********** | ********** | ********** | ********** | ********** | |
Net Profit After Taxes | ********** | ********** | ********** | ********** | ********** | |
% of N.P.A.T. To Net Sales | ********** | ********** | ********** | ********** | ********** | |
Debt Service Coverage Ratio | ********** | ********** | ********** | ********** | ********** | |
Debt Service Coverage Ratio | ||||||
Funds Available to Service Debts | ||||||
Net Profit After Taxes | ********** | ********** | ********** | ********** | ********** | |
Depreciation Charges | ********** | ********** | ********** | ********** | ********** | |
Technical Knowhow Fees & Exp | ********** | ********** | ********** | ********** | ********** | |
Interest on Long/Medium Term | ********** | ********** | ********** | ********** | ********** | |
Total | ********** | ********** | ********** | ********** | ********** | |
Debt Service Obligations | ||||||
Repayment of Long/Medium Term | ********** | ********** | ********** | ********** | ********** | |
Interest on Long/Medium Term | ********** | ********** | ********** | ********** | ********** | |
Total | ********** | ********** | ********** | ********** | ********** | |
********** | ********** | ********** | ********** | ********** | ||
D. S. C. R. (Individual) | ********** | ********** | ********** | ********** | ********** | |
D. S. C. R. (Cumulative) | ********** | ********** | ********** | ********** | ********** | |
D. S. C. R. (Overall) | ********** | ********** | ********** | ********** | ********** | |
Parameters | ||||||
Initial Equity Capital | ********** | ********** | ********** | ********** | ********** | ********** |
Credit Balance in P & L | ********** | ********** | ********** | ********** | ********** | ********** |
Total Capital exclUnsec Deposits | ********** | ********** | ********** | ********** | ********** | ********** |
Unsecured Dep. | ********** | ********** | ********** | ********** | ********** | ********** |
Total Equity incl Unsecured Deposits | ********** | ********** | ********** | ********** | ********** | ********** |
Long/Medium Term Borrowings from Bank | ********** | ********** | ********** | ********** | ********** | ********** |
Term lia. Incl Unsecured Deposit | ********** | ********** | ********** | ********** | ********** | ********** |
Total Liabilities | ********** | ********** | ********** | ********** | ********** | ********** |
Total Liabilities incl Unsecured Deposits | ********** | ********** | ********** | ********** | ********** | ********** |
DEBT EQUITY RATIO considering | ********** | ********** | ********** | ********** | ********** | ********** |
DEBT EQUITY RATIO considering | ||||||
I.E.Total Term Lia./NW | ||||||
Unsecured Dep. as Equity | ********** | ********** | ********** | ********** | ********** | ********** |
Unsecured Dep. as Debt | ********** | ********** | ********** | ********** | ********** | ********** |
Total Outside Lia./NW | ********** | ********** | ********** | ********** | ********** | ********** |
Total Outside Lia./NW | ********** | ********** | ********** | ********** | ********** | |
Assets Turnover Ratio (x) | ********** | ********** | ********** | ********** | ********** | |
No. of Shares of 10.00 each | ********** | ********** | ********** | ********** | ********** | |
Earnings Per Share (EPS) (in) | ********** | ********** | ********** | ********** | ********** | |
Proposed divident | ********** | ********** | ********** | ********** | ********** | |
Cash EPS (in) | ********** | ********** | ********** | ********** | ********** | |
Dividend Per Share(DPS) (in) | ********** | ********** | ********** | ********** | ********** | |
Payout Ratio (%Age) | ********** | ********** | ********** | ********** | ********** | |
Retained Earnings/Share (in) | ********** | ********** | ********** | ********** | ********** | |
Retained Earnings (%Age) | ********** | ********** | ********** | ********** | ********** | |
Book Value Per Share (in) | ********** | ********** | ********** | ********** | ********** | |
Debt Per Share (in) | ********** | ********** | ********** | ********** | ********** | |
Probable Mkt. Price/Share(in) | ********** | ********** | ********** | ********** | ********** | |
Price / Book Value (x) | ********** | ********** | ********** | ********** | ********** | |
Price Earnings Ratio (x) | ********** | ********** | ********** | ********** | ********** | |
Yield (%Age) | ********** | ********** | ********** | ********** | ********** |
PARTICULARS | OPERATING YEARS | |||||
---|---|---|---|---|---|---|
Ratio | 1-2 | 2-3 | 3-4 | 4-5 | 5-6 | |
BREAK EVEN ANALYSIS | ||||||
Total Value of Output | ********** | ********** | ********** | ********** | ********** | |
Variable Cost & Expenses | ||||||
Raw Material Cost | ********** | ********** | ********** | ********** | ********** | ********** |
Lab & ETP Chemical Cost | ********** | ********** | ********** | ********** | ********** | ********** |
Packing Material Cost | ********** | ********** | ********** | ********** | ********** | ********** |
Sales Commission/Exp. | ********** | ********** | ********** | ********** | ********** | ********** |
Sub-total | ********** | ********** | ********** | ********** | ********** | |
Less: W.I.P. Adjustments | ********** | ********** | ********** | ********** | ********** | |
Total Variable Cost | ********** | ********** | ********** | ********** | ********** | |
Net Contribution | ********** | ********** | ********** | ********** | ********** | |
Profit Volume Ratio (%) | ********** | ********** | ********** | ********** | ********** | |
Semi-Var./Semi-Fixed Exp. | ********** | ********** | ********** | ********** | ********** | ********** |
Miscellaneous Cost | ********** | ********** | ********** | ********** | ********** | ********** |
Employees Expenses | ********** | ********** | ********** | ********** | ********** | ********** |
Power/Electricity Expen | ********** | ********** | ********** | ********** | ********** | ********** |
Fuel Expenses | ********** | ********** | ********** | ********** | ********** | ********** |
Royalty & Other Charges | ********** | ********** | ********** | ********** | ********** | ********** |
Repairs & Maintenance E | ********** | ********** | ********** | ********** | ********** | ********** |
Other Mfg. Expenses | ********** | ********** | ********** | ********** | ********** | ********** |
Administration Expenses | ********** | ********** | ********** | ********** | ********** | ********** |
Selling Expenses | ********** | ********** | ********** | ********** | ********** | ********** |
Interest on Wkg.Capital | ********** | ********** | ********** | ********** | ********** | ********** |
Tot.Semi-Var./Fixed Exp. | ********** | ********** | ********** | ********** | ********** | ********** |
Fixed Expenses / Cost | ********** | ********** | ********** | ********** | ********** | ********** |
Miscellaneous Cost | ********** | ********** | ********** | ********** | ********** | ********** |
Employees Expenses | ********** | ********** | ********** | ********** | ********** | ********** |
Power/Electricity Expen | ********** | ********** | ********** | ********** | ********** | ********** |
Fuel Expenses | ********** | ********** | ********** | ********** | ********** | ********** |
Royalty & Other Charges | ********** | ********** | ********** | ********** | ********** | ********** |
Repairs & Maintenance E | ********** | ********** | ********** | ********** | ********** | ********** |
Other Mfg. Expenses | ********** | ********** | ********** | ********** | ********** | ********** |
Administration Expenses | ********** | ********** | ********** | ********** | ********** | ********** |
Selling Expenses | ********** | ********** | ********** | ********** | ********** | ********** |
Intrest-Fixed Borrowing | ********** | ********** | ********** | ********** | ********** | ********** |
Intrest-Working Capital | ********** | ********** | ********** | ********** | ********** | ********** |
Depreciation Charges | ********** | ********** | ********** | ********** | ********** | ********** |
Deferred Expenses W/Off | ********** | ********** | ********** | ********** | ********** | ********** |
Total Fixed Expenses | ********** | ********** | ********** | ********** | ********** | ********** |
Tot.Fixed/Semi-Fixed Exp | ********** | ********** | ********** | ********** | ********** | ********** |
Tot.Cash Fixed/SemiFixed | ********** | ********** | ********** | ********** | ********** | ********** |
Cash Break Even Sales | ********** | ********** | ********** | ********** | ********** | ********** |
Cash Margin of Safety | ********** | ********** | ********** | ********** | ********** | ********** |
Break Even Sales | ********** | ********** | ********** | ********** | ********** | ********** |
Margin of safety | ********** | ********** | ********** | ********** | ********** | ********** |
At Maximum Utilisation : | Year | ********** | ********** | ********** | ********** | ********** |
(as % of Installed Capacity) | ||||||
Cash B.E.P. : | % | xx% | xx% | xx% | xx% | xx% |
B.E.P. : | % | xx% | xx% | xx% | xx% | xx% |
MEANS OF FINANCE | |||
---|---|---|---|
Equity Share Capital | ********** | ********** | ********** |
Others - Preference Share Capital | ********** | ********** | ********** |
Total Equity Share Capital | ********** | ********** | ********** |
********** | ********** | ********** | |
Long/Medium Term Borrowings | ********** | ********** | ********** |
FROM BANK | ********** | ********** | ********** |
From Other Financial Institutions | ********** | ********** | ********** |
Total Long/Medium Term Borrowings | ********** | ********** | ********** |
********** | ********** | ********** | |
Total Means of Finance | ********** | ********** | ********** |
PARTICULARS | OPERATING YEARS | ||||
---|---|---|---|---|---|
1-2 | 2-3 | 3-4 | 4-5 | 5-6 | |
Equity Share Capital | ********** | ********** | ********** | ********** | ********** |
Surplus of Previous Year | ********** | ********** | ********** | ********** | ********** |
Add : Net Profit After Taxes | ********** | ********** | ********** | ********** | ********** |
Surplus at the End of Year | ********** | ********** | ********** | ********** | ********** |
Unsecured Deposits | ********** | ********** | ********** | ********** | ********** |
Long/Medium Term Borrowings Proposed-FROM BANK | ********** | ********** | ********** | ********** | ********** |
Bank Borrowing for Wkg. Capital | ********** | ********** | ********** | ********** | ********** |
Current Liabilities | ********** | ********** | ********** | ********** | ********** |
Sundry Creditors | ********** | ********** | ********** | ********** | ********** |
Other Current Liabilities | ********** | ********** | ********** | ********** | ********** |
Total Current Liabilities | ********** | ********** | ********** | ********** | ********** |
********** | ********** | ********** | ********** | ********** | |
Total of Liabilities | ********** | ********** | ********** | ********** | ********** |
********** | ********** | ********** | ********** | ********** | |
ASSETS | ********** | ********** | ********** | ********** | ********** |
Fixed Assets | ********** | ********** | ********** | ********** | ********** |
Gross Block | ********** | ********** | ********** | ********** | ********** |
Less : Depreciation to Date | ********** | ********** | ********** | ********** | ********** |
Net Block | ********** | ********** | ********** | ********** | ********** |
Current Assets | ********** | ********** | ********** | ********** | ********** |
Stocks on Hand | ********** | ********** | ********** | ********** | ********** |
Receivables | ********** | ********** | ********** | ********** | ********** |
Other Current Assets | ********** | ********** | ********** | ********** | ********** |
Cash and Bank Balances | ********** | ********** | ********** | ********** | ********** |
Total Current Assets | ********** | ********** | ********** | ********** | ********** |
P & P Exp. and/or Other Dvp.Exp. | ********** | ********** | ********** | ********** | ********** |
(To The Extent Not W/Off) | ********** | ********** | ********** | ********** | ********** |
Other Non Current Assets | ********** | ********** | ********** | ********** | ********** |
********** | ********** | ********** | ********** | ********** | |
Total of Assets | ********** | ********** | ********** | ********** | ********** |
ROI (Average of Fixed Assets) | ********** | ********** | ********** | ********** | ********** |
RONW (Average of Share Capital) | ********** | ********** | ********** | ********** | ********** |
ROI (Average of Total Assets) | ********** | ********** | ********** | ********** | ********** |
INTEREST AND REPAYMENT ON TERM LOANS
A | Name of Institution-Bank | ABC BANK | |
---|---|---|---|
B | Term Borrowing Amount | ********** | xx |
C | Repayment Term (Years) | ********** | Years |
D | Repayment Instalments | ********** | Instalments |
E | Repayment Commencement | Year - 0; 3rd Qtr. | |
F | Rate of Interest(General) | xxxx% | p.a. |
G | Rate of Interest(Initial) | 0.00% | p.a. |
H | Apply Gen. Int. Rate from Year | x Quarter :: x | |
I | Interest Calculation | Quarterly |
Debt Service Coverage Ratio | ||||||
---|---|---|---|---|---|---|
Funds Available to Service Debts | ||||||
Net Profit After Taxes | ********** | ********** | ********** | ********** | ********** | |
Depreciation Charges | ********** | ********** | ********** | ********** | ********** | |
Technical Knowhow Fees & Expenses | ********** | ********** | ********** | ********** | ********** | |
Interest on Long/Medium Term | ********** | ********** | ********** | ********** | ********** | |
Total | ********** | ********** | ********** | ********** | ********** | |
Debt Service Obligations | ********** | ********** | ********** | ********** | ********** | |
Repayment of Long/Medium Term | ********** | ********** | ********** | ********** | ********** | |
Interest on Long/Medium Term | ********** | ********** | ********** | ********** | ********** | |
Total | ********** | ********** | ********** | ********** | ********** | |
********** | ********** | ********** | ********** | ********** | ||
D. S. C. R. (Individual) | ********** | ********** | ********** | ********** | ********** | |
D. S. C. R. (Cumulative) ..... | ********** | ********** | ********** | ********** | ********** | |
D. S. C. R. (Overall) ........ | ********** | ********** | ********** | ********** | ********** |
DEPRECIATION CHARGES AS PER BOOKS (TOTAL)
Operating Year | F.Assets Type A-1 | F.Assets Type A-2 | F.Assets Type B | F.Assets Type C | F.Assets Type D-1 | F.Assets Type D-2 | Total |
---|---|---|---|---|---|---|---|
Particulars | Factory Building | Office Buildings | Plant & Machinery | Office Vehicles | Office Automation Equipments (Telephone/ Fax/ Computer) | Furniture & Fixtures | |
1-2 | ********** | ********** | ********** | ********** | ********** | ********** | ********** |
********** | ********** | ********** | ********** | ********** | ********** | ********** | |
********** | ********** | ********** | ********** | ********** | ********** | ********** | |
2-3 | ********** | ********** | ********** | ********** | ********** | ********** | ********** |
********** | ********** | ********** | ********** | ********** | ********** | ********** | |
********** | ********** | ********** | ********** | ********** | ********** | ********** | |
3-4 | ********** | ********** | ********** | ********** | ********** | ********** | ********** |
********** | ********** | ********** | ********** | ********** | ********** | ********** | |
********** | ********** | ********** | ********** | ********** | ********** | ********** | |
4-5 | ********** | ********** | ********** | ********** | ********** | ********** | ********** |
********** | ********** | ********** | ********** | ********** | ********** | ********** | |
********** | ********** | ********** | ********** | ********** | ********** | ********** | |
5-6 | ********** | ********** | ********** | ********** | ********** | ********** | ********** |
********** | ********** | ********** | ********** | ********** | ********** | ********** | |
********** | ********** | ********** | ********** | ********** | ********** | ********** |
Particulars | Method | Deprn.Rate | Part Consideration (for Asset put to use less than xx months) |
---|---|---|---|
Type A :: Buildings | |||
Factory Building - | WDV | ********** | ********** |
Office Buildings | WDV | ********** | ********** |
Type C | |||
Office Vehicles | WDV | ********** | ********** |
Type D :: Misc. Fixed Assets | |||
Office Automation Equipments (Telephone/ Fax/ Computer) | WDV | ********** | ********** |
Furniture & Fixtures | WDV | ********** | ********** |
Type B :: Plant & Machineries |
Projected Pay Back Period | |||||
---|---|---|---|---|---|
Particulars | Operating Years | ||||
1-2 | 2-3 | 3-4 | 4-5 | 5-6 | |
Year | 1 | 2 | 3 | 4 | 5 |
Initial Investment | ********* | ||||
Total Initial Investment | ********* | ||||
Yearly Cash Flow | ********* | ********* | ********* | ********* | ********* |
Accumulated Cash Flow | ********* | ********* | ********* | ********* | ********* |
Accumulated Cash Flow | ********* | ********* | ********* | ********* | ********* |
Pay Back Period | xx Years xx Months | xx Years xx months |
Projected IRR | |||||
---|---|---|---|---|---|
Year | CFAT | PV factor @**% | ********* | ||
Initial Investment | ********* | ********* | ********* | ||
1-2 | ********* | ********* | ********* | ||
2-3 | ********* | ********* | ********* | ||
3-4 | ********* | ********* | ********* | ||
4-5 | ********* | ********* | ********* | ||
5-6 | ********* | ********* | ********* | ||
Total PV | ********* | ********* | |||
IRR | ********* | ********* | |||
NIIR PROJECT CONSULTANCY SERVICES (NPCS) is a reliable name in the industrial world for offering integrated technical consultancy services. NPCS is manned by engineers, planners, specialists, financial experts, economic analysts and design specialists with extensive experience in the related industries.
Our various services are: Detailed Project Report, Business Plan for Manufacturing Plant, Start-up Ideas, Business Ideas for Entrepreneurs, Start up Business Opportunities, entrepreneurship projects, Successful Business Plan, Industry Trends, Market Research, Manufacturing Process, Machinery, Raw Materials, project report, Cost and Revenue, Pre-feasibility study for Profitable Manufacturing Business, Project Identification, Project Feasibility and Market Study, Identification of Profitable Industrial Project Opportunities, Business Opportunities, Investment Opportunities for Most Profitable Business in India, Manufacturing Business Ideas, Preparation of Project Profile, Pre-Investment and Pre-Feasibility Study, Market Research Study, Preparation of Techno-Economic Feasibility Report, Identification and Selection of Plant, Process, Equipment, General Guidance, Startup Help, Technical and Commercial Counseling for setting up new industrial project and Most Profitable Small Scale Business.
NPCS also publishes varies process technology, technical, reference, self employment and startup books, directory, business and industry database, bankable detailed project report, market research report on various industries, small scale industry and profit making business. Besides being used by manufacturers, industrialists and entrepreneurs, our publications are also used by professionals including project engineers, information services bureau, consultants and project consultancy firms as one of the input in their research.
- This report helps you to identify a profitable project for investing or diversifying into by throwing light to crucial areas like industry size, demand of the product and reasons for investing in the product.
- This report provides vital information on the product like its definition, characteristics and segmentation.
- This report helps you market and place the product correctly by identifying the target customer group of the product.
- This report helps you understand the viability of the project by disclosing details like raw materials required, manufacturing process, project costs and snapshot of other project financials.
- The report provides forecasts of key parameters which helps to anticipate the industry performance and make sound business decision.
- Our research reports broadly cover Indian markets, present analysis, outlook and forecast.
- The market forecasts are developed on the basis of secondary research and are cross-validated through interactions with the industry players.
- We use reliable sources of information and databases. And information from such sources is processed by us and included in the report.
Introduction
- Project Introduction
- Project Objective and Strategy
- Concise History of the Product
- Properties
- BIS (Bureau of Indian Standards) Provision & Specification
- Uses & Applications
Market Study and Assessment
- Current Indian Market Scenario
- Present Market Demand and Supply
- Estimated Future Market Demand and Forecast
- Statistics of Import & Export
- Names & Addresses of Existing Units (Present Players)
- Market Opportunity
Raw Material
- List of Raw Materials
- Properties of Raw Materials
- Prescribed Quality of Raw Materials
- List of Suppliers and Manufacturers
Personnel (Manpower) Requirements
- Requirement of Staff & Labor (Skilled and Unskilled) Managerial, Technical, Office Staff and Marketing Personnel
Plant and Machinery
- List of Plant & Machinery
- Miscellaneous Items
- Appliances &Equipments
- Laboratory Equipments& Accessories
- Electrification
- Electric Load & Water
- Maintenance Cost
- Sources of Plant & Machinery (Suppliers and Manufacturers)
Manufacturing Process and Formulations
- Detailed Process of Manufacture with Formulation
- Packaging Required
- Process Flow Sheet Diagram
Infrastructure and Utilities
- Project Location
- Requirement of Land Area
- Rates of the Land
- Built Up Area
- Construction Schedule
- Plant Layout and Requirement of Utilities
- Assumptions for Profitability workings
- Plant Economics
- Production Schedule
-
- Land & Building
- Factory Land & Building
- Site Development Expenses
-
- Plant & Machinery
- Indigenous Machineries
- Other Machineries (Miscellaneous, Laboratory etc.)
-
- Other Fixed Assets
- Furniture & Fixtures
- Pre-operative and Preliminary Expenses
- Technical Knowhow
- Provision of Contingencies
-
- Working Capital Requirement Per Month
- Raw Material
- Packing Material
- Lab & ETP Chemical Cost
- Consumable Store
-
- Overheads Required Per Month And Per Annum
- Utilities & Overheads (Power, Water and Fuel Expenses etc.)
- Royalty and Other Charges
- Selling and Distribution Expenses
- Salary and Wages
- Turnover Per Annum
-
- Share Capital
- Equity Capital
- Preference Share Capital
- Annexure 1:: Cost of Project and Means of Finance
-
- Annexure 2:: Profitability and Net Cash Accruals
- Revenue/Income/Realisation
- Expenses/Cost of Products/Services/Items
- Gross Profit
- Financial Charges
- Total Cost of Sales
- Net Profit After Taxes
- Net Cash Accruals
-
- Annexure 3 :: Assessment of Working Capital requirements
- Current Assets
- Gross Working. Capital
- Current Liabilities
- Net Working Capital
- Working Note for Calculation of Work-in-process
- Annexure 4 :: Sources and Disposition of Funds
-
- Annexure 5 :: Projected Balance Sheets
- ROI (Average of Fixed Assets)
- RONW (Average of Share Capital)
- ROI (Average of Total Assets)
-
- Annexure 6 :: Profitability ratios
- D.S.C.R
- Earnings Per Share (EPS)
- Debt Equity Ratio
-
- Annexure 7 :: Break-Even Analysis
- Variable Cost & Expenses
- Semi-Var./Semi-Fixed Exp.
- Profit Volume Ratio (PVR)
- Fixed Expenses / Cost
- B.E.P
-
- Annexure 8 to 11:: Sensitivity Analysis-Price/Volume
- Resultant N.P.B.T
- Resultant D.S.C.R
- Resultant PV Ratio
- Resultant DER
- Resultant ROI
- Resultant BEP
-
- Annexure 12 :: Shareholding Pattern and Stake Status
- Equity Capital
- Preference Share Capital
-
- Annexure 13 :: Quantitative Details-Output/Sales/Stocks
- Determined Capacity P.A of Products/Services
- Achievable Efficiency/Yield % of Products/Services/Items
- Net Usable Load/Capacity of Products/Services/Items
- Expected Sales/ Revenue/ Income of Products/ Services/ Items
- Annexure 14 :: Product wise domestic Sales Realisation
- Annexure 15 :: Total Raw Material Cost
- Annexure 16 :: Raw Material Cost per unit
- Annexure 17 :: Total Lab & ETP Chemical Cost
- Annexure 18 :: Consumables, Store etc.,
- Annexure 19 :: Packing Material Cost
- Annexure 20 :: Packing Material Cost Per Unit
- Annexure 21 :: Employees Expenses
- Annexure 22 :: Fuel Expenses
- Annexure 23 :: Power/Electricity Expenses
- Annexure 24 :: Royalty & Other Charges
- Annexure 25 :: Repairs & Maintenance Exp.
- Annexure 26 :: Other Mfg. Expenses
- Annexure 27 :: Administration Expenses
- Annexure 28 :: Selling Expenses
- Annexure 29 :: Depreciation Charges – as per Books (Total)
- Annexure 30 :: Depreciation Charges – as per Books (P & M)
- Annexure 31 :: Depreciation Charges - As per IT Act WDV (Total)
- Annexure 32 :: Depreciation Charges - As per IT Act WDV (P & M)
- Annexure 33 :: Interest and Repayment - Term Loans
- Annexure 34 :: Tax on Profits
- Annexure 35 ::Projected Pay-Back Period And IRR
- One Lac / Lakh / Lakhs is equivalent to one hundred thousand (100,000)
- One Crore is equivalent to ten million (10,000,000)
- T.C.I is Total Capital Investment
- We can modify the project capacity and project cost as per your requirement.
- We can also prepare project report on any subject as per your requirement.
- Caution: The project's cost, capacity and return are subject to change without any notice. Future projects may have different values of project cost, capacity or return.
Need assistance?
Share your details, we will call you
NIIR PROJECT CONSULTANCY SERVICES (NPCS) is a reliable name in the industrial world for offering integrated technical consultancy services.
Read more →Quick Links
Products & Services
Contact Info
106-E, Kamla Nagar,
New Delhi-110007, India. |
|
+91 9097-075-054, +91-11-23843955, +91-11-23845886 Any quries? Call us. |
|
[email protected]
Any quries? Mail Now. |
- Copyright © 2024 NPCS, All Right Reserved.
X
Have a business idea? Let’s make it
happen together-contact us now!